A comprehensive predictive model for radiation-induced brain injury in risk stratification and personalized radiotherapy of nasopharyngeal carcinoma.

He, Yong-Qiao; Wang, Tong-Min; Yang, Da-Wei; Xue, Wen-Qiong; Deng, Chang-Mi; Li, Dan-Hua; Zhang, Wen-Li; Liao, Ying et al. · Radiother Oncol · 2024

retrospective_cohort · Level III

Where this comes from

Abstract

Radiation-induced brain injury (RBI) is a severe radiotoxicity for nasopharyngeal carcinoma (NPC) patients, greatly affecting their long-term life quality and survival. We aim to establish a comprehensive predictive model including clinical factors and newly developed genetic variants to improve the precision of RBI risk stratification. By performing a large registry-based retrospective study with magnetic resonance imaging follow-up on RBI development, we conducted a genome-wide association study and developed a polygenic risk score (PRS) for RBI in 1189 NPC patients who underwent intensity-modulated radiotherapy. We proposed a tolerance dose scheme for temporal lobe radiation based on the risk predicted by PRS. Additionally, we established a nomogram by combining PRS and clinical factors for RBI risk prediction. The 38-SNP PRS could effectively identify high-risk individuals of RBI (P = 1.42 × 10<sup>-34</sup>). Based on genetic risk calculation, the recommended tolerance doses of temporal lobes should be 57.6 Gy for individuals in the top 10 % PRS subgroup and 68.1 Gy for individuals in the bottom 50 % PRS. Notably, individuals with high genetic risk (PRS > P<sub>50</sub>) and receiving high radiation dose in the temporal lobes (D<sub>0.5CC</sub> > 65 Gy) had an approximate 50-fold risk over individuals with low PRS and receiving low radiation dose (HR = 50.09, 95 %CI = 24.27-103.35), showing an additive joint effect (P<sub>interaction</sub> < 0.001). By combining PRS with clinical factors including age, tumor stage, and radiation dose of temporal lobes, the predictive accuracy was significantly improved with C-index increased from 0.78 to 0.85 (P = 1.63 × 10<sup>-2</sup>). The PRS, together with clinical factors, could improve RBI risk stratification and implies personalized radiotherapy.

Medical subject headings